文献速递肿瘤 PET/CT核素与放射性配体治疗

治疗前18F-FDG PET/CT与MRI影像组学预测局部晚期宫颈癌放化疗结局

Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-12-09

本研究纳入102例接受放化疗的局部晚期宫颈癌患者(训练集69例、测试集33例),治疗前采集18F-FDG PET/CT与MRI(含DWI)影像并提取影像组学特征。多因素分析显示PET的GLRLM灰度非均匀性(GLNUGLRLM)和DWI-ADC图的GLCM熵(EntropyGLCM)为独立预后因素,测试集中预测复发准确率94%、预测局部区域控制失败准确率100%,显著高于临床参数(约50-60%)。

要点

  • PET的GLNUGLRLM与DWI-ADC图的EntropyGLCM为独立预后因素
  • 测试集预测复发准确率94%、预测局部区域控制失败准确率100%
  • 临床参数预测准确率约50-60%,影像组学显著更高

核心结论

  • 在局部晚期宫颈癌放化疗患者中,DWI-MRI的EntropyGLCM和PET的GLNUGLRLM是复发与局部区域控制的独立预测因素,预后预测能力显著高于常规临床参数。
  • 作者认为需要进一步研究对这些特征进行验证,或可据此对复发高风险患者采取更积极的治疗。

研究设计与样本

  • 回顾性纳入2010年8月至2016年12月接受放化疗的局部晚期宫颈癌患者102例,其中训练集69例、测试集33例。
  • 每例患者治疗前均行18F-FDG PET/CT与MRI检查(T1、T2、T1C、DWI)。
  • PET图像用模糊局部自适应贝叶斯算法、MRI图像用3D Slicer勾画原发肿瘤体积,提取强度、形状和纹理影像组学特征。
  • 比较影像组学特征与临床参数对无复发生存和局部区域控制的预后价值。

主要发现

  • 训练集中位随访3.0年(范围0.43-6.56年),36%的患者出现复发。
  • 单因素分析中,FIGO分期(I-II期 vs III-IV期)和代谢反应(完全 vs 非完全)可能与结局相关但未达统计学显著,而PET和MRI序列的多个影像组学特征与结局相关。
  • 训练集多因素分析确定PET的GLRLM灰度非均匀性(GLNUGLRLM)和DWI-MRI的ADC图GLCM熵(EntropyGLCM)为独立预后因素。
  • 测试集中上述特征的预后预测能力显著高于临床参数:预测复发准确率94%,预测局部区域控制失败准确率100%,临床参数约为50-60%。

关键数值与推荐

  • 影像组学特征预测复发准确率94%(测试集)。
  • 影像组学特征预测局部区域控制失败准确率100%(测试集)。
  • 临床参数预测准确率约50-60%(测试集)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要进一步研究验证这些影像组学特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study is to determine if radiomics features from 18fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI) images could contribute to prognoses in cervical cancer. METHODS: One hundred and two patients (69 for training and 33 for testing) with locally advanced cervical cancer (LACC) receiving chemoradiotherapy (CRT) from 08/2010 to 12/2016 were enrolled in this study. 18F-FDG PET/CT and MRI examination [T1, T2, T1C, diffusion-weighted imaging (DWI)] were performed for each patient before CRT. Primary tumor volumes were delineated with the fuzzy locally adaptive Bayesian algorithm in the PET images and with 3D Slicer™ in the MRI images. Radiomics features (intensity, shape, and texture) were extracted and their prognostic value was compared with clinical parameters for recurrence-free and locoregional control. RESULTS: In the training cohort, median follow-up was 3.0 years (range, 0.43-6.56 years) and relapse occurred in 36% of patients. In univariate analysis, FIGO stage (I-II vs. III-IV) and metabolic response (complete vs. non-complete) were probably associated with outcome without reaching statistical significance, contrary to several radiomics features from both PET and MRI sequences. Multivariate analysis in training test identified Grey Level Non UniformityGLRLM in PET and EntropyGLCM in ADC maps from DWI MRI as independent prognostic factors. These had significantly higher prognostic power than clinical parameters, as evaluated in the testing cohort with accuracy of 94% for predicting recurrence and 100% for predicting lack of loco-regional control (versus ~50-60% for clinical parameters). CONCLUSIONS: In LACC treated with CRT, radiomics features such as EntropyGLCM and GLNUGLRLM from functional imaging DWI-MRI and PET, respectively, are independent predictors of recurrence and loco-regional control with significantly higher prognostic power than usual clinical parameters. Further research is warranted for their validation, which may justify more aggressive treatment in patients identified with high probability of recurrence.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lucia F, Visvikis D, Desseroit MC, et al. Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2017. PMID: 29222685. doi:10.1007/s00259-017-3898-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。